EUVIMEDEUVIMED entdecken
Multizentrische Studie

Impact of endoscopic ultrasound-guided fine-needle biopsy on management of suspected small (11–20 mm) and very small (≤10 mm) low-risk nonfunctioning pancreatic neuroendocrine tumors

Stefano Francesco Crinó iD, Maria Cristina Conti Bellocchi, Piero Tavian, Nicolò De Pretis, Sokol Sina, Claudio Luchini, Jayanta Samanta iD, Jahnvi Dhar, Gianenrico Rizzatti, Giulia Palumbo, Alberto Larghi iD, Cristiano Spada und 6 weitere

Endoscopy · 01.08.2026 · 58 (08) · 872-881

DOI: 10.1055/a-2863-1084 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Endoscopy, erschienen am 01.08.2026. Verfasst von Stefano Francesco Crinó und 17 weiteren Autor:innen. Beteiligte Einrichtung: University of Verona, Department of Medicine, Pancreas Institute, Italy, Verona. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Neuroendocrine Tumors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of routine endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) of small (≤20 mm) nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) remains debated. We evaluated the impact of EUS-FNB on clinical management of very small (≤10 mm) and small (11–20 mm) suspected NF-PanNETs in patients who were otherwise suitable for active surveillance.

Methods

This was a retrospective analysis of patients with single, sporadic, ≤20-mm lesions, exhibiting typical imaging features of NF-PanNET, who were referred for EUS-FNB at two high-volume centers (January 2017–December 2024). The primary outcome was impact of EUS-FNB on management (a diagnosis leading to a strategy other than active surveillance). Secondary outcomes included factors associated with substantial management change, sample adequacy, safety, Ki-67 assessment, and concordance between EUS-FNB and surgical grading.

Results

417 lesions (160 [very small]; 257 [small]) were included. EUS-FNB changed management in 68 cases (16.3%), more frequently in small lesions (19.8% vs. 10.6%; P = 0.01). A substantial impact leading to surgical resection was more frequent in small lesions (12.4% vs. 3.7%; P = 0.002). Lesion size 11–20 mm was independently associated with substantial impact (odds ratio 3.19, 95%CI 1.05–9.66). Sample adequacy was 96.1%, adverse event rate was 3.4%, Ki-67 was feasible in 96.0% of confirmed PanNETs, and grading concordance with surgical specimens was 78.1%.

Conclusions

In patients with suspected small NF-PanNET without suspicious features, EUS-FNB provided a clear clinical benefit for larger lesions (11–20 mm). For very small lesions (≤10 mm), its more limited impact supports individualized, shared decision making with the patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsEndoscopic Ultrasound-Guided Fine Needle AspirationNeuroendocrine TumorsHumansFemaleRetrospective StudiesMaleMiddle AgedAgedTumor Burden

Autor:innen und Institutionen

  • University of Verona, Department of Medicine, Pancreas Institute, Italy, Verona.
  • Verona University Hospital Trust, Diagnostic and Interventional Endoscopy of the Pancreas, Italy, Verona.
  • Verona University Hospital Trust, Gastroenterology Unit, Italy, Verona.
  • University and Hospital Trust of Verona, Department of Diagnostics and Public Health, Section of Pathology, Italy, Verona.
  • University and Hospital Trust of of Verona, Department of Diagnostics and Public Health, Section of Pathology, Italy, Verona.
  • University of Verona, ARC-Net Research Centre, Italy, Verona.

ORCID-Profile: Stefano Francesco Crinó, Jayanta Samanta, Alberto Larghi, Antonio Facciorusso, Salvatore Paiella

Zitieren

APA

Crinó, S. F., Conti Bellocchi, M. C., Tavian, P., De Pretis, N., Sina, S., Luchini, C., Samanta, J., Dhar, J., Rizzatti, G., Palumbo, G., Larghi, A., Spada, C., Facciorusso, A., D'Onofrio, M., Salvia, R., Paiella, S., Frulloni, L., & Landoni, L. (2026). Impact of endoscopic ultrasound-guided fine-needle biopsy on management of suspected small (11–20 mm) and very small (≤10 mm) low-risk nonfunctioning pancreatic neuroendocrine tumors. Endoscopy, 58(08), 872-881. https://doi.org/10.1055/a-2863-1084

Vancouver

Crinó SF, Conti Bellocchi MC, Tavian P, De Pretis N, Sina S, Luchini C, et al. Impact of endoscopic ultrasound-guided fine-needle biopsy on management of suspected small (11–20 mm) and very small (≤10 mm) low-risk nonfunctioning pancreatic neuroendocrine tumors. Endoscopy. 2026;58(08):872-881. doi:10.1055/a-2863-1084

BibTeX
@article{Crin2026,
  author = {Crinó, Stefano Francesco and Conti Bellocchi, Maria Cristina and Tavian, Piero and De Pretis, Nicolò and Sina, Sokol and Luchini, Claudio and Samanta, Jayanta and Dhar, Jahnvi and Rizzatti, Gianenrico and Palumbo, Giulia and Larghi, Alberto and Spada, Cristiano and Facciorusso, Antonio and D'Onofrio, Mirko and Salvia, Roberto and Paiella, Salvatore and Frulloni, Luca and Landoni, Luca},
  title = {Impact of endoscopic ultrasound-guided fine-needle biopsy on management of suspected small (11–20 mm) and very small (≤10 mm) low-risk nonfunctioning pancreatic neuroendocrine tumors},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {08},
  pages = {872--881},
  doi = {10.1055/a-2863-1084}
}
Kostenlos starten →